HIV molecular immunology database
ISRKAKGWFYRHHYESTHPR
|
Vif(31-50) | human epitope |
RKAKGWFYRHHYESTHPR
|
Vif(33-50) | human epitope |
GKAKGWFYRHHYESTHPR
|
Vif(33-50) | human epitope |
RHHYESRHPKVSSEVHI
|
Vif(41-57) | B*15:10 human epitope |
RHHYESRHPKVSSEVyI
|
Vif(41-57) | observed variant |
RHHYESRHPiVSSEVyI
|
Vif(41-57) | observed variant |
RHHYESRHPKVSSEVHI
|
Vif(41-57) | B*15:10 human epitope |
SPHPRISSEV
|
Vif(46-55) | B*07 human, transgenic mouse epitope |
StHPRISSEV
|
Vif(46-55) | susceptible form |
HPRVSSEVHI
|
Vif(48-57) | B*07 human epitope |
HPRISSEVHI
|
Vif(48-57) | B*07 human, transgenic mouse epitope |
HPkISSEVHI
|
Vif(48-57) | non-susceptible form |
HPRvSSEVHI
|
Vif(48-57) | non-susceptible form |
HPRVSSEVHI
|
Vif(48-57) | B*07:02 human epitope |
HPRVSSEVHI
|
Vif(48-57) | B*07:02 human epitope |
HPRVSSEVHI
|
Vif(48-57) | B*07:02 human epitope |
HPRISSEVHI
|
Vif(48-57) | B*07:02 human epitope |
HPRvSSEVHI
|
Vif(48-57) | diminished response; escape documented in this paper; non-susceptible form |
HPkISSEVHI
|
Vif(48-57) | diminished response; escape documented in this paper; non-susceptible form |
HPRVSSEVHI
|
Vif(48-57) | B*07:02 human epitope |
HPRISSEVHI
|
Vif(48-57) | B*07:02 human epitope |
HPkISSEVHI
|
Vif(48-57) | subtype-specific non-susceptible form |
HPRVSSEVHI
|
Vif(48-57) | B*18 human epitope |
HPRVSSEVHI
|
Vif(48-57) | B*27 human epitope |
HPKVSSEVHI
|
Vif(48-57) | B*42 human epitope |
HPKVSSEVHv
|
Vif(48-57) | observed variant |
HPKVSSEiHI
|
Vif(48-57) | observed variant |
HPKVSSEVHt
|
Vif(48-57) | observed variant |
nPKVSSEVHI
|
Vif(48-57) | observed variant |
HPKiSSEVHI
|
Vif(48-57) | observed variant |
HPrVSSEVHI
|
Vif(48-57) | observed variant |
HPKVSSEVHI
|
Vif(48-57) | B*42:01 human epitope |
HPKVSSEVHI
|
Vif(48-57) | B*42:01 human epitope |
HPKVSSEVHI
|
Vif(48-57) | B*42:01 human epitope |
HPKVSSEVHI
|
Vif(48-57) | B*42:01 human epitope |
HPKVSSEVHI
|
Vif(48-57) | B*42:01 human epitope |
nPKVSSEVHI
|
Vif(48-57) | escape documented in this paper; observed variant |
HPRVSSEVHI
|
Vif(48-57) | B*42:01 human epitope |
HPRVSSEVHI
|
Vif(48-57) | B*51 human epitope |
HPRISSEVHI
|
Vif(48-57) | B7 human epitope |
HPkISSEVHI
|
Vif(48-57) | susceptible form |
HPRISSEVHI
|
Vif(48-57) | B7 human epitope |
HPKISSEVHI
|
Vif(48-57) | B7 human epitope |
HPRVSSEVHI
|
Vif(48-57) | B7 human epitope |
HPRISSEVHI
|
Vif(48-57) | B7 human epitope |
HPRVSSEVHI
|
Vif(48-57) | B7 human epitope |
HPKISSEVHI
|
Vif(48-57) | B7 human epitope |
HPRISSEVHI
|
Vif(48-57) | B7 human epitope |
HPKVSSEVHI
|
Vif(48-57) | human epitope |
HPRVSSEVHI
|
Vif(48-57) | human epitope |
HPKVSSEVHIA
|
Vif(48-58) | B*42:01 human epitope |
xPKVSSEVHIa
|
Vif(48-58) | escape documented in this paper |
ISSEVHIPLGDARLVITTYW
|
Vif(51-70) | human epitope |
EVHIPLGDAR
|
Vif(54-63) | A*68:01 human epitope |
EVHIPLGeAR
|
Vif(54-63) | observed variant |
EVHIPLGDAk
|
Vif(54-63) | observed variant |
EVHIPvGDAR
|
Vif(54-63) | observed variant |
EVHIPLGDgR
|
Vif(54-63) | observed variant |
EVHIPLGEAR
|
Vif(54-63) | A*68:01 human epitope |
EVHIPLGEAk
|
Vif(54-63) | observed variant |
aVHIPLGEAi
|
Vif(54-63) | observed variant |
EVHIPLGEAR
|
Vif(54-63) | A*68:01 human epitope |
HIPLGEARLVIKTYWGL
|
Vif(56-72) | C*12 human epitope |
HIPLGEARLVIKTYWGL
|
Vif(56-72) | human epitope |
IPLGEAKLV
|
Vif(57-65) | B7 human epitope |
IPLGDAKLII
|
Vif(57-66) | A*30 human epitope |
IPLGDAKLII
|
Vif(57-66) | A*74 human epitope |
IPLGDARLVI
|
Vif(57-66) | B*07 human, transgenic mouse epitope |
IPLGDARLVv
|
Vif(57-66) | susceptible form |
IPLGDAKLII
|
Vif(57-66) | B*07 human epitope |
IPLGDAKLII
|
Vif(57-66) | B*18 human epitope |
IPLGDAKLII
|
Vif(57-66) | B*51 human epitope |
IPLGDALKII
|
Vif(57-66) | B*51 human epitope |
IPLGDAKLII
|
Vif(57-66) | B*51 human epitope |
IPLGDAKLII
|
Vif(57-66) | B51 human epitope |
IPLGDARLVI
|
Vif(57-66) | B7 human epitope |
IPLGDAKLII
|
Vif(57-66) | B*81 human epitope |
IPLGDAKLII
|
Vif(57-66) | C*14 human epitope |
IPLGDAKLII
|
Vif(57-66) | human epitope |
IPLGDAKLVITTYWG
|
Vif(57-71) | B*51 epitope |